The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Self-citationJani, P. U., Florence, A. T., & McCarthy, D. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90162-u · Cited by 136
Hillery, A. M., & Florence, A. T. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04353-5 · Cited by 81
Mucoadhesion of Latexes. I. Analytical Methods and Kinetic Studies
Durrer, C., Irache, J. M., Puisieux, F., Duchêne, D., & Ponchel, G. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968011169 · Cited by 41
Cited by
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Self-citationKawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,000
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Self-citationNanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study
Bhawana, Basniwal, R. K., Buttar, H. S., Jain, V. K., & Jain, N. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf104402t · Cited by 863
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs
Vo, C. L.-N., Park, C., & Lee, B.-J. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.09.007 · Cited by 651
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
Lu, Y., & Park, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.042 · Cited by 572
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439
Self-citationPreparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
The production and characteristics of solid lipid nanoparticles (SLNs)
Hou, D., Xie, C., Huang, K., & Zhu, C. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00578-1 · Cited by 437
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 420
Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation
Liu, Y., Cheng, C., Liu, Y., Prud’homme, R. K., & Fox, R. O. (2008) · Chemical Engineering Science · doi:10.1016/j.ces.2007.10.020 · Cited by 395
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120030422 · Cited by 387
Micron‐Size Drug Particles: Common and Novel Micronization Techniques
Rasenack, N., & Müller, B. W. (2004) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120027417 · Cited by 357
Mucoadhesion: A promising approach in drug delivery system
Mansuri, S., Kesharwani, P., Jain, K., Tekade, R. K., & Jain, N. K. (2016) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2016.01.011 · Cited by 351
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Self-citationProgress, challenges, and future of nanomedicine
Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 318
Production and characterization of Hesperetin nanosuspensions for dermal delivery
Mishra, P. R., Shaal, L. A., Müller, R. H., & Keck, C. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.030 · Cited by 308
Self-citationBuparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability
Müller, R. H., & Jacobs, C. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00040-6 · Cited by 280
Self-citationNanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Kakran, M., Sahoo, N. G., Tan, I.-L., & Li, L. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0757-0 · Cited by 265
Metadata
- Authors
- Müller, R., Jacobs, C., & Kayser, O.
- Venue
- Drugs and the Pharmaceutical Sciences
- Publisher
- CRC Press
- Published
- 2000-02-25
- Pages
- 383-407
- ISSN
- 0360-2583 (ISSN-L)
- 2154-5219
- OpenAlex
- W4251505294
- Cited by
- 501
- References
- 4
- FWCI
- 61.17
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.